Why the study?
Does the use of LGE-CMR to guide LV lead deployment away from scarred myocardium improve clinical outcomes in patients undergoing CRT compared to a conventional implantation approach?
Does the use of LGE-CMR to guide LV lead deployment away from scarred myocardium improve clinical outcomes in patients undergoing CRT compared to a conventional implantation approach?
Answers are grounded in this paper and cite their sources.
Using LGE-CMR to avoid pacing scarred myocardium during CRT implantation improves clinical outcomes and reduces the risk of pump failure and sudden cardiac death.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Leyva et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: